Philipp Zwickel
University Hospital Heidelberg
Publications 3
#1Annika GaussH-Index: 8
#2Thomas GeibH-Index: 1
Last.Lukas KluteH-Index: 1
view all 8 authors...
To formulate therapy goals, we aimed to define the relationship between fecal calprotectin and health-related quality of life in inflammatory bowel diseases (IBDs). This retrospective single-center cross-sectional study included ambulatory IBD patients who had completed standardized questionnaires comprising items of health-related quality of life (Short Inflammatory Bowel Disease Questionnaire) and clinical disease activity scores, and who had provided stool samples for calprotectin determinati...
3 CitationsSource
AIM: To evaluate the outcome of anti-tumor necrosis factor alpha (anti-TNFα) therapy in outpatients with ulcerative colitis at a tertiary referral center. METHODS: All patients with a confirmed diagnosis of ulcerative colitis undergoing therapy with infliximab and/or adalimumab at the outpatient clinic for inflammatory bowel diseases at the University Hospital Heidelberg between January 2011 and February 2014 were retrospectively enrolled. Patients with a follow-up period of less than 6 mo from ...
9 CitationsSource
#1Christian Rupp (University Hospital Heidelberg)H-Index: 15
#2Esther Herpel (University Hospital Heidelberg)H-Index: 28
Last.Annika Gauss (University Hospital Heidelberg)H-Index: 8
view all 9 authors...
Introduction Pouchitis often occurs after proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis. It is usually deemed idiopathic and commonly responds to antibacterial therapy. To date, only a few cases of cytomegalovirus pouchitis have been documented, and only a single report describes pouchitis in a case of assumed primary cytomegalovirus infection.